250 related articles for article (PubMed ID: 33612481)
1. Overexpression of hsa_circ_0002874 promotes resistance of non-small cell lung cancer to paclitaxel by modulating miR-1273f/MDM2/p53 pathway.
Xu J; Ni L; Zhao F; Dai X; Tao J; Pan J; Shi A; Shen Z; Su C; Zhang Y
Aging (Albany NY); 2021 Feb; 13(4):5986-6009. PubMed ID: 33612481
[TBL] [Abstract][Full Text] [Related]
2. MiR-221-3p-mediated downregulation of MDM2 reverses the paclitaxel resistance of non-small cell lung cancer in vitro and in vivo.
Ni L; Xu J; Zhao F; Dai X; Tao J; Pan J; Shi A; Shen Z; Su C; Zhang Y
Eur J Pharmacol; 2021 May; 899():174054. PubMed ID: 33771522
[TBL] [Abstract][Full Text] [Related]
3. Circular RNA hsa_circ_0014130 Inhibits Apoptosis in Non-Small Cell Lung Cancer by Sponging miR-136-5p and Upregulating BCL2.
Geng Y; Bao Y; Zhang W; Deng L; Su D; Zheng H
Mol Cancer Res; 2020 May; 18(5):748-756. PubMed ID: 32060230
[TBL] [Abstract][Full Text] [Related]
4. Hsa_circ_0092887 targeting miR-490-5p/UBE2T promotes paclitaxel resistance in non-small cell lung cancer.
Wang L; Zhang Z; Tian H
J Clin Lab Anal; 2023 Jan; 37(1):e24781. PubMed ID: 36550019
[TBL] [Abstract][Full Text] [Related]
5. hsa_circ_0058357 acts as a ceRNA to promote non‑small cell lung cancer progression via the hsa‑miR‑24‑3p/AVL9 axis.
Wei D; Sun L; Feng W
Mol Med Rep; 2021 Jun; 23(6):. PubMed ID: 33880595
[TBL] [Abstract][Full Text] [Related]
6. Downregulation of hsa_circ_0007580 inhibits non-small cell lung cancer tumorigenesis by reducing miR-545-3p sponging.
Chen S; Lu S; Yao Y; Chen J; Yang G; Tu L; Zhang Z; Zhang J; Chen L
Aging (Albany NY); 2020 Jul; 12(14):14329-14340. PubMed ID: 32681720
[TBL] [Abstract][Full Text] [Related]
7. HSA_CIRC_0004050 on proliferation and apoptosis of A549 cells through ERK/JNK signaling pathway.
Wang Y; Zang RK; Du YN
J Biol Regul Homeost Agents; 2020; 34(6):2037-2047. PubMed ID: 33348975
[TBL] [Abstract][Full Text] [Related]
8. Blocking hsa_circ_0074027 suppressed non-small cell lung cancer chemoresistance via the miR-379-5p/IGF1 axis.
Zheng S; Wang C; Yan H; Du Y
Bioengineered; 2021 Dec; 12(1):8347-8357. PubMed ID: 34592879
[TBL] [Abstract][Full Text] [Related]
9. p38 MAPK-induced MDM2 degradation confers paclitaxel resistance through p53-mediated regulation of EGFR in human lung cancer cells.
Park SH; Seong MA; Lee HY
Oncotarget; 2016 Feb; 7(7):8184-99. PubMed ID: 26799187
[TBL] [Abstract][Full Text] [Related]
10. Hsa_circ_0001869 promotes NSCLC progression via sponging miR-638 and enhancing FOSL2 expression.
Xu P; Wang L; Xie X; Hu F; Yang Q; Hu R; Jiang L; Ding F; Mei J; Liu J; Xiao H
Aging (Albany NY); 2020 Nov; 12(23):23836-23848. PubMed ID: 33221767
[TBL] [Abstract][Full Text] [Related]
11. circRNA hsa_circ_0005909 Predicts Poor Prognosis and Promotes the Growth, Metastasis, and Drug Resistance of Non-Small-Cell Lung Cancer via the miRNA-338-3p/SOX4 Pathway.
Song HM; Meng D; Wang JP; Zhang XY
Dis Markers; 2021; 2021():8388512. PubMed ID: 34413915
[TBL] [Abstract][Full Text] [Related]
12. Circular RNA hsa_circ_0096157 contributes to cisplatin resistance by proliferation, cell cycle progression, and suppressing apoptosis of non-small-cell lung carcinoma cells.
Lu H; Xie X; Wang K; Chen Q; Cai S; Liu D; Luo J; Kong J
Mol Cell Biochem; 2020 Dec; 475(1-2):63-77. PubMed ID: 32767026
[TBL] [Abstract][Full Text] [Related]
13. Suppression of Circular RNA Hsa_circ_0109320 Attenuates Non-Small Cell Lung Cancer Progression via MiR-595/E2F7 Axis.
Bai Q; Li L; Chen F; Zhu J; Cao L; Yang Y; Zhong F
Med Sci Monit; 2020 Jun; 26():e921200. PubMed ID: 32508344
[TBL] [Abstract][Full Text] [Related]
14. Curcumin suppresses the malignancy of non-small cell lung cancer by modulating the circ-PRKCA/miR-384/ITGB1 pathway.
Xu X; Zhang X; Zhang Y; Wang Z
Biomed Pharmacother; 2021 Jun; 138():111439. PubMed ID: 33684690
[TBL] [Abstract][Full Text] [Related]
15. Microarray profiles reveal that circular RNA hsa_circ_0007385 functions as an oncogene in non-small cell lung cancer tumorigenesis.
Jiang MM; Mai ZT; Wan SZ; Chi YM; Zhang X; Sun BH; Di QG
J Cancer Res Clin Oncol; 2018 Apr; 144(4):667-674. PubMed ID: 29372377
[TBL] [Abstract][Full Text] [Related]
16. Circular RNA hsa_circ_0102231 sponges miR-145 to promote non-small cell lung cancer cell proliferation by up-regulating the expression of RBBP4.
Cao X; Li F; Shao J; Lv J; Chang A; Dong W; Zhu F
J Biochem; 2021 Feb; 169(1):65-73. PubMed ID: 33084863
[TBL] [Abstract][Full Text] [Related]
17. Fuzheng Kang-Ai inhibits NSCLC cell proliferation via regulating hsa_circ_0048091/hsa-miR-378g/ARRDC3 pathway.
Tang Q; Wang X; Zhou Q; Li Q; Yang X; Xu M; Wang R; Chen J; Wu W; Wang S
Phytomedicine; 2023 Jun; 114():154819. PubMed ID: 37062135
[TBL] [Abstract][Full Text] [Related]
18. Enhanced expression of circular RNA hsa_circ_000984 promotes cells proliferation and metastasis in non-small cell lung cancer by modulating Wnt/β-catenin pathway.
Li XY; Liu YR; Zhou JH; Li W; Guo HH; Ma HP
Eur Rev Med Pharmacol Sci; 2019 Apr; 23(8):3366-3374. PubMed ID: 31081091
[TBL] [Abstract][Full Text] [Related]
19. Circ-RNF111 contributes to paclitaxel resistance in breast cancer by elevating E2F3 expression via miR-140-5p.
Zang H; Li Y; Zhang X; Huang G
Thorac Cancer; 2020 Jul; 11(7):1891-1903. PubMed ID: 32445273
[TBL] [Abstract][Full Text] [Related]
20. A novel circular RNA hsa_circRNA_103809/miR-377-3p/GOT1 pathway regulates cisplatin-resistance in non-small cell lung cancer (NSCLC).
Zhu X; Han J; Lan H; Lin Q; Wang Y; Sun X
BMC Cancer; 2020 Dec; 20(1):1190. PubMed ID: 33276753
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
